First Time Loading...

Crinetics Pharmaceuticals Inc
NASDAQ:CRNX

Watchlist Manager
Crinetics Pharmaceuticals Inc Logo
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Watchlist
Price: 46.86 USD -1.29% Market Closed
Updated: May 29, 2024

EV/EBITDA
Enterprise Value to EBITDA

-11.3
Current
-5.4
Median
4.8
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-11.3
=
Enterprise Value
2.8B
/
EBITDA
-246.9m
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-9.2
2-Years Forward
EV/EBITDA
-9.2
3-Years Forward
EV/EBITDA
-9.7

See Also

Discover More